227 related articles for article (PubMed ID: 27062698)
1. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.
Zhang X; Guo M; Fan J; Lv Z; Huang Q; Han J; Wu F; Hu G; Xu J; Jin Y
Cancer Biomark; 2016; 16(3):415-23. PubMed ID: 27062698
[TBL] [Abstract][Full Text] [Related]
2. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
3. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
5. Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer.
Deng T; Zhang J; Meng Y; Zhou Y; Li W
Medicine (Baltimore); 2018 Sep; 97(38):e12524. PubMed ID: 30235773
[TBL] [Abstract][Full Text] [Related]
6. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
[TBL] [Abstract][Full Text] [Related]
7. Factors confounding evaluation of treatment effect in lung cancer.
Osterlind K
Lung Cancer; 1994 Mar; 10 Suppl 1():S97-103. PubMed ID: 8087532
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
Koh YW; Lee SJ; Park SY
Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
[TBL] [Abstract][Full Text] [Related]
9. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
[TBL] [Abstract][Full Text] [Related]
10. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.
Tas F; Aydiner A; Demir C; Topuz E
Am J Clin Oncol; 2001 Aug; 24(4):376-8. PubMed ID: 11474266
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis.
Zhuo Y; Lin L; Wei S; Zhang M
Medicine (Baltimore); 2016 Dec; 95(52):e5706. PubMed ID: 28033270
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
14. Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Chen D; Mao Y; Wen J; She Y; Zhu E; Zhu F; Zhang Y; Fan M; Chen C; Chen Y
Ann Thorac Surg; 2019 Sep; 108(3):945-954. PubMed ID: 30914285
[TBL] [Abstract][Full Text] [Related]
15. Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients.
Cao S; Jin S; Shen J; Cao J; Zhang H; Meng Q; Wang C; Zhang A; Zhang P; Yu Y
Oncotarget; 2017 Jan; 8(5):8657-8669. PubMed ID: 28055965
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis.
Tian Z; Liang C; Zhang Z; Wen H; Feng H; Ma Q; Liu D; Qiang G
World J Surg Oncol; 2020 May; 18(1):116. PubMed ID: 32473655
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
